EZH2 and neoplasm: Recent studies showed that expression of Ezh2 is correlated with the worse outcome of patients with hepatocellular carcinoma (HCC), and regulates proliferation and tumorigenicity of tumor-spheres derived from HCC cell lines [29], [30].